You just read:

LGC Capital's Leading Australian Medical Cannabis LP Partner, Little Green Pharma, Commences Commercial Sales to Patients, Has Its Products Accepted for Major Clinical Trials, Commences Negotiations to Export to Germany and Announces Plans for a New 500,000 Square Foot Site

News provided by

LGC Capital Ltd.

05 Oct, 2018, 12:30 BST